https://www.selleckchem.com/pr....oducts/cenicriviroc.
Moreover, our data suggest that ABCB1 is not a major mechanism of resistance to erdafitinib in cancer cells. In conclusion, we revealed an additional action of erdafitinib as a potential treatment option for multidrug-resistant cancers, which should be evaluated in future drug combination trials.Background We investigated the association of waist circumference (WC) and abdominal obesity with the incident colorectal cancer risk in Korean adults. Methods This nationwide population-based cohort study was based on health insurance clai
Like
Comment
Share
